AU Stock MarketDetailed Quotes

NEU Neuren Pharmaceuticals Ltd

Watchlist
  • 13.300
  • +0.190+1.45%
20min DelayNot Open Feb 17 16:00 AET
1.73BMarket Cap11.06P/E (Static)

Neuren Pharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Neuren Pharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 108.600M--
--2024/H124.327M / 24.100M--
Feb 29, 20242023/H2168.999M / 169.600M--
Aug 28, 20232023/H164.405M / 63.100M--
--2022/H216.750M / 13.900M--
DatePeriodRevenue/EstimateEarnings Call
--2024/H2-- / 108.600M--
--2024/H124.327M / 24.100M--
Feb 29, 20242023/H2168.999M / 169.600M--
Aug 28, 20232023/H164.405M / 63.100M--
--2022/H216.750M / 13.900M--

Unlock Free Earnings Estimates

Neuren Pharmaceuticals Ltd Earnings Reports

  • Neuren Pharmaceuticals Ltd: Q3 2024 update

    Nov 6, 2024 18:19 ET

  • Neuren Pharmaceuticals Ltd: H1 2024 financial results

    Aug 26, 2024 19:17 ET

  • Neuren Pharmaceuticals Ltd: Half Yearly Report and Accounts

    Aug 26, 2024 19:12 ET

  • Neuren Pharmaceuticals Ltd: 2023 Annual Report to shareholders

    Apr 22, 2024 19:16 ET

    • Read more

    Trending Stocks
    ASX High Dividend ASX High Dividend
    Symbol Div YieldTTM Dividend TTM
    Origin Energy Ltd
    ORG
    4.48% 0.48
    Rio Tinto Ltd
    RIO
    5.26% 6.36
    Telstra Group Ltd
    TLS
    4.51% 0.18
    CommBank
    CBA
    2.82% 4.65
    BHP Group Ltd
    BHP
    5.59% 2.28

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 16, 2025

    Strong Buy

    • Strong Buy

      66.67%

    • Buy

      33.33%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data